Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan P Schneck

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Clinical Immunology (Orlando, Fla.)|March 30, 2004
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagementMathias Oelke, Jonathan P Schneck
Immunologic Research|January 21, 2010
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansionMathias Oelke, Jonathan P Schneck
The Journal of Clinical Investigation|December 12, 2018
High-affinity T cell receptors for adoptive cell transferAriel Isser, Jonathan P Schneck
Journal of Visualized Experiments : Jove|December 4, 2018
Enrich and Expand Rare Antigen-specific T Cells with Magnetic NanoparticlesJohn W Hickey, Jonathan P Schneck
Clinical and Diagnostic Laboratory Immunology|March 5, 2002
Development and use of multimeric major histocompatibility complex moleculesTim F Greten, Jonathan P Schneck
Trends in Molecular Medicine|May 4, 2004
Quality and quantity: new strategies to improve immunotherapy of cancerChristine Krueger, Jonathan P Schneck, Mathias Oelke
Drugs of Today (Barcelona, Spain : 1998)|March 9, 2005
Technological advances in adoptive immunotherapyMathias Oelke, Christine Krueger, Jonathan P Schneck
Biomaterials|December 18, 2020
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapyAriel Isser, Natalie K Livingston, Jonathan P Schneck
Gels (Basel, Switzerland)|November 26, 2025
Hydrogels in the Immune Context: In Vivo Applications for Modulating Immune Responses in Cancer TherapyMara R Lanis, Sujin Kim, Jonathan P Schneck
Biochimica Et Biophysica Acta|September 10, 2014
Linking form to function: Biophysical aspects of artificial antigen presenting cell designKarlo Perica, Alyssa K Kosmides, Jonathan P Schneck
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Clinical Immunology (Orlando, Fla.)|March 30, 2004
HLA-Ig-based artificial antigen-presenting cells: setting the terms of engagementMathias Oelke, Jonathan P Schneck
Immunologic Research|January 21, 2010
Overview of a HLA-Ig based "Lego-like system" for T cell monitoring, modulation and expansionMathias Oelke, Jonathan P Schneck
The Journal of Clinical Investigation|December 12, 2018
High-affinity T cell receptors for adoptive cell transferAriel Isser, Jonathan P Schneck
Journal of Visualized Experiments : Jove|December 4, 2018
Enrich and Expand Rare Antigen-specific T Cells with Magnetic NanoparticlesJohn W Hickey, Jonathan P Schneck
Clinical and Diagnostic Laboratory Immunology|March 5, 2002
Development and use of multimeric major histocompatibility complex moleculesTim F Greten, Jonathan P Schneck
Trends in Molecular Medicine|May 4, 2004
Quality and quantity: new strategies to improve immunotherapy of cancerChristine Krueger, Jonathan P Schneck, Mathias Oelke
Drugs of Today (Barcelona, Spain : 1998)|March 9, 2005
Technological advances in adoptive immunotherapyMathias Oelke, Christine Krueger, Jonathan P Schneck
Biomaterials|December 18, 2020
Biomaterials to enhance antigen-specific T cell expansion for cancer immunotherapyAriel Isser, Natalie K Livingston, Jonathan P Schneck
Gels (Basel, Switzerland)|November 26, 2025
Hydrogels in the Immune Context: In Vivo Applications for Modulating Immune Responses in Cancer TherapyMara R Lanis, Sujin Kim, Jonathan P Schneck
Biochimica Et Biophysica Acta|September 10, 2014
Linking form to function: Biophysical aspects of artificial antigen presenting cell designKarlo Perica, Alyssa K Kosmides, Jonathan P Schneck
Pageof 9